The Nifty 50 index experienced a decline of 1.50%, closing at 23,815.85 on May 11, 2023, driven by concerns over US-Iran talks and rising crude oil prices. Amid this market volatility, experts recommend focusing on stocks with solid fundamentals. Vishnu Kant Upadhyay from Master Capital Services suggests Emcure Pharmaceuticals with target prices of ₹1,820 and ₹1,860, noting its strong bullish setup despite a recent pullback. Coal India, closing at ₹464.45, is also highlighted, with target prices of ₹495 and ₹510, reflecting a structurally strong uptrend. Additionally, Zydus Lifesciences is recommended with a target of ₹1,020 and ₹1,040 due to its recent breakout and bullish momentum. Hitesh Tailor from Choice Broking adds Torrent Pharmaceuticals to the list, targeting ₹4,900, and Welspun Corp with a target of ₹1,450. Lastly, Sharda Cropchem is noted for its strong price structure with a target of ₹1,270. Investors are advised to consult certified experts before making decisions due to rapidly changing market conditions.